Contract award
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB)
- PIID
- 75N95020F00001
- Award key
- CONT_AWD_75N95020F00001_7529_HHSN271201700017I_7529
- Recipient UEI
- MBT9RXJJ7428
- Parent award
- CONT_IDV_HHSN271201700017I_7529
- Source as of
- —
Current award value
$5,298,4973
Obligated to date
$5,298,4972
Potential with options
$8,098,4663
- Awarding agency
- Department of Health and Human ServicesNational Institutes of Health
- Contractor
- LOVELACE BIOMEDICAL RESEARCH INSTITUTE
- Place of performance
- Albuquerque, New Mexico
- Set-aside
- None
- Pricing
- Cost Plus Fixed Fee
- Competition
- Full and Open Competition3 offers received
- Period of performance
- Sep 25, 2020 — May 31, 2027Through May 31, 2027 if all options are exercised
- Benchmark category
- Unclassified
Transaction history
Every action recorded against this award, in the order the government reported them.
| Mod | Action date | Reason | Obligation | Value at action |
|---|---|---|---|---|
| 0 | Sep 23, 2020 | Initial award | $2,269,992.00 | $5,298,497.16 |
| P00001 | Nov 19, 2021 | D | $0.00 | $5,298,497.16 |
| P00002 | May 19, 2022 | B | $0.00 | $5,298,497.16 |
| P00003 | May 24, 2023 | B | $0.00 | $5,298,497.16 |
| P00004 | Nov 21, 2023 | B | $0.00 | $5,298,497.16 |
| P00005 | Dec 20, 2024 | B | $0.00 | $5,298,497.16 |
| P00006 | May 19, 2025 | G | $1,745,514.00 | $5,298,497.16 |
| P00007 | May 29, 2026 | B | $1,282,991.16 | $5,298,497.16 |
Provenance
Which source record produced each displayed rollup figure.
| Field | Source | File | Retrieved | Parser | Artifact hash |
|---|---|---|---|---|---|
| awarding_agency_id | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | adf73415cbda |
| contractor_id | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | adf73415cbda |
| current_award_value | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | adf73415cbda |
| naics_code | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | adf73415cbda |
| potential_award_value | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | adf73415cbda |
| psc_code | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | adf73415cbda |
| total_obligated | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | adf73415cbda |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.
- 1Rollup values derive from 8 transaction records parsed from USAspending.gov, retrieved Aug 10, 2026 by transform awards@2026.08.1.
- 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
- 3Current and potential award values are taken from the latest reported action, not summed across modifications.